S Hopf1, N Pfeiffer2. 1. Augenklinik und Poliklinik, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland. susanne.hopf@unimedizin-mainz.de. 2. Augenklinik und Poliklinik, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland.
Abstract
BACKGROUND: Myopia is the most common cause for impaired vision in children and young adults with increasing tendency. Although myopia is hereditary, genetic findings do not explain the full extent of its recent increase. Epidemiologic studies are required to investigate the prevalence and incidence of this disease. OBJECTIVES: The prevalence, incidence and progression of myopia with its economic impact are emphasized to review the distribution and consequences of the development and progression of myopia. METHODS: A systematic literature search was conducted in MEDLINE. RESULTS: The global prevalence of myopia is currently 28.3 % and is dramatically increasing. In 2050, half of the world population will be affected. Myopia starts earlier and exhibits a peak prevalence in young Asian adults. High myopia indicates a similar development. Interventions to slow the development and progression of myopia are strongly required due to the medical and socio-economic drawbacks for the individuals and for society. CONCLUSION: Myopia is already a ubiquitous phenomenon in some parts of the world. One out of ten persons will be at a relevant risk of becoming blind as a result of myopia in the future. Preventive measures have not shown sweeping success.
BACKGROUND:Myopia is the most common cause for impaired vision in children and young adults with increasing tendency. Although myopia is hereditary, genetic findings do not explain the full extent of its recent increase. Epidemiologic studies are required to investigate the prevalence and incidence of this disease. OBJECTIVES: The prevalence, incidence and progression of myopia with its economic impact are emphasized to review the distribution and consequences of the development and progression of myopia. METHODS: A systematic literature search was conducted in MEDLINE. RESULTS: The global prevalence of myopia is currently 28.3 % and is dramatically increasing. In 2050, half of the world population will be affected. Myopia starts earlier and exhibits a peak prevalence in young Asian adults. High myopia indicates a similar development. Interventions to slow the development and progression of myopia are strongly required due to the medical and socio-economic drawbacks for the individuals and for society. CONCLUSION:Myopia is already a ubiquitous phenomenon in some parts of the world. One out of ten persons will be at a relevant risk of becoming blind as a result of myopia in the future. Preventive measures have not shown sweeping success.
Authors: Brien A Holden; Timothy R Fricke; David A Wilson; Monica Jong; Kovin S Naidoo; Padmaja Sankaridurg; Tien Y Wong; Thomas J Naduvilath; Serge Resnikoff Journal: Ophthalmology Date: 2016-02-11 Impact factor: 12.079
Authors: Jenny M Ip; Seang-Mei Saw; Kathryn A Rose; Ian G Morgan; Annette Kifley; Jie Jin Wang; Paul Mitchell Journal: Invest Ophthalmol Vis Sci Date: 2008-07 Impact factor: 4.799
Authors: Phillippa M Cumberland; Yanchun Bao; Pirro G Hysi; Paul J Foster; Christopher J Hammond; Jugnoo S Rahi Journal: PLoS One Date: 2015-10-02 Impact factor: 3.240
Authors: Brien A Holden; David A Wilson; Monica Jong; Padmaja Sankaridurg; Timothy R Fricke; Earl L Smith; Serge Resnikoff Journal: Community Eye Health Date: 2015
Authors: Katie M Williams; Virginie J M Verhoeven; Phillippa Cumberland; Geir Bertelsen; Christian Wolfram; Gabriëlle H S Buitendijk; Albert Hofman; Cornelia M van Duijn; Johannes R Vingerling; Robert W A M Kuijpers; René Höhn; Alireza Mirshahi; Anthony P Khawaja; Robert N Luben; Maja Gran Erke; Therese von Hanno; Omar Mahroo; Ruth Hogg; Christian Gieger; Audrey Cougnard-Grégoire; Eleftherios Anastasopoulos; Alain Bron; Jean-François Dartigues; Jean-François Korobelnik; Catherine Creuzot-Garcher; Fotis Topouzis; Cécile Delcourt; Jugnoo Rahi; Thomas Meitinger; Astrid Fletcher; Paul J Foster; Norbert Pfeiffer; Caroline C W Klaver; Christopher J Hammond Journal: Eur J Epidemiol Date: 2015-03-18 Impact factor: 8.082
Authors: Ladislav Janco; Katarina Tkacova-Villemova; Anna Matisovska; Maria Mesarosova; Marta Ondrejkova; Alexandra Kollarova; Matus Rehak Journal: Int Ophthalmol Date: 2019-05-25 Impact factor: 2.031